Tag: pro-tumor inflammation

Novartis has provided the updates on the Canopy-A Phase III. Photo credit: National Cancer Institute on Unsplash

Phase III study for lung cancer treatment did not meet goal...

0
Healthcare company Novartis has announced that its Phase III of the Canopy-A trial using canakinumab as an additional medicine in treating non-small cell lung...

This function has been disabled for HealthTekPak.

error: Content is protected !!